These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2442602)

  • 1. Low natural killer syndrome: clinical and immunologic features.
    Aoki T; Usuda Y; Miyakoshi H; Tamura K; Herberman RB
    Nat Immun Cell Growth Regul; 1987; 6(3):116-28. PubMed ID: 2442602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired in vitro interferon, blastogenic, and natural killer cell responses to viral stimulation in acquired immune deficiency syndrome.
    Hersh EM; Gutterman JU; Spector S; Friedman H; Greenberg SB; Reuben JM; LaPushin R; Matza M; Mansell PW
    Cancer Res; 1985 Jan; 45(1):406-10. PubMed ID: 2578099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome.
    Caligiuri M; Murray C; Buchwald D; Levine H; Cheney P; Peterson D; Komaroff AL; Ritz J
    J Immunol; 1987 Nov; 139(10):3306-13. PubMed ID: 2824604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological abnormalities in intravenous drug abusers and relationship to the prolonged generalized lymphadenopathy syndrome in Italy.
    De Paoli P; Reitano M; Battistin S; Martelli P; Villalata D; Bergamo F; Tirelli U; Carbone A; Diodato S; Bosio R
    Clin Exp Immunol; 1986 Jun; 64(3):451-6. PubMed ID: 3024880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
    Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
    J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of whole blood methods in assessment of immune parameters in immunodeficiency states.
    Fletcher MA; Baron GC; Ashman MR; Fischl MA; Klimas NG
    Diagn Clin Immunol; 1987; 5(2):69-81. PubMed ID: 3113759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
    Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG
    J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-associated histiocytic proliferations in children. Frequent association with Epstein-Barr virus and congenital or acquired immunodeficiencies.
    McClain K; Gehrz R; Grierson H; Purtilo D; Filipovich A
    Am J Pediatr Hematol Oncol; 1988; 10(3):196-205. PubMed ID: 2845831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell function in severe combined immunodeficiency (SCID): evidence of a common T and NK cell defect in some but not all SCID patients.
    Peter HH; Friedrich W; Dopfer R; Müller W; Kortmann C; Pichler WJ; Heinz F; Rieger CH
    J Immunol; 1983 Nov; 131(5):2332-9. PubMed ID: 6415162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in natural killer cells and natural killer T cells during acute viral hepatitis E.
    Srivastava R; Aggarwal R; Bhagat MR; Chowdhury A; Naik S
    J Viral Hepat; 2008 Dec; 15(12):910-6. PubMed ID: 18673427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cells and cytomegalovirus and Epstein-Barr virus infection in cardiac graft recipients.
    Korcáková L; Kaslík J; Svobodová J; Nozicková M; Horák J; Kocandrle V; Fabián J; Raska I; Lejnar J; Franková V
    Cor Vasa; 1988; 30(6):435-41. PubMed ID: 2853033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
    Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
    Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acquired immunodeficiency syndrome (AIDS).
    Rosen FS
    J Clin Invest; 1985 Jan; 75(1):1-3. PubMed ID: 3155526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
    Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
    Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of a minor subpopulation of peripheral blood lymphocytes (T8+/Leu 7+) in patients with haemophilia.
    Ziegler-Heitbrock HW; Schramm W; Stachel D; Rumpold H; Kraft D; Wernicke D; von der Helm K; Eberle J; Deinhardt F; Rieber EP
    Clin Exp Immunol; 1985 Sep; 61(3):633-41. PubMed ID: 4075588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2-dependent natural killer (NK) cell lines from patients with primary T cell immunodeficiencies.
    Flomenberg N; Welte K; Mertelsmann R; O'Reilly R; Dupont B
    J Immunol; 1983 Jun; 130(6):2635-43. PubMed ID: 6222110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.